Core Viewpoint - The company has shown improvement in financial performance, expanding its business scale, deepening the application of digital platforms, and experiencing a clear trend of industry concentration, attracting institutional attention [1]. Financial Performance - For the first three quarters of 2025, the company reported revenue of 609 million, a year-on-year increase of 2.59%, and a net profit attributable to shareholders of 87.38 million, up 20.92%. In the third quarter alone, revenue reached 219 million, reflecting a year-on-year growth of 9.84%, while net profit surged by 91.6% to 33.23 million, with a gross margin increase to 25.58% [2]. Business Development - As of the end of September 2025, the company has undertaken over 4,200 international and domestic SMO projects, with 2,538 projects currently in execution. The service scope includes the top ten global pharmaceutical companies in 2024, such as Merck and AstraZeneca, indicating a quarterly growth trend in project numbers and demonstrating business resilience [3]. Technological Advancements - The company has developed its own platform, the "Rui Xing" intelligent management system, which integrates AI functionalities to enhance the efficiency of clinical trials. Investor relations activities in 2025 indicated that this platform has achieved data visualization and intelligent management, contributing to improved service quality [4]. Industry Environment - According to investor activities in February 2026, resources in the SMO industry are gradually concentrating towards leading enterprises. As a leading company, the firm benefits from regulatory policy support and accumulated customer resources, optimizing the competitive landscape of the industry [5]. Institutional Interest - In January 2026, the company hosted discussions with several institutions, including Huatai PineBridge Fund, focusing on business strategy and quality management systems. Over the past year, the company has received a total of 210 institutional visits, reflecting a high level of market interest [6].

Company Performance - The net profit for 2025 reached $6.837 billion, representing a year-on-year growth of 16.77%, significantly higher than the growth rate in 2024 [2] - Despite a 0.75% decline in revenue to $59.32 billion, the company achieved an organic growth rate of 2.0%, indicating the effectiveness of its premiumization strategy [2] Business Development - The sales volume of non-beer products continues to expand, with non-alcoholic beer revenue growing over 20%, and products like Corona Zero maintaining a leading position in key markets [3] - The company has driven an increase in average price through a super-premium product mix (e.g., Corona, Hoegaarden), partially offsetting a total sales volume decline of 2.54% [3] Digital and Sustainability Initiatives - The B2B platform BEES achieved a total GMV of $49 billion, covering 28 markets, with 75% of revenue generated through digital channels [4] - The company accelerated its carbon neutrality efforts, with 81.2% of operational electricity sourced from renewable power, and a 29.5% reduction in carbon intensity compared to 2017 [4] Industry Context - The Asia-Pacific market was impacted by a 13.1% revenue decline in China, although South Korea achieved a ten-year high in market share [5] - The North American market stabilized its share through premium brands like Michelob, while the Latin American market benefited from double-digit growth in Brazil [5]

（来源：中国医药报） 转自：中国医药报 □ 宋红霞 魏畅 赵元煜 多方协同筑牢保障 为确保平台发挥实效，河北省药监局积极构建多维度协同保障机制，全方位推动平台高效运行与服务优 化。 医疗器械临床成果转化，曾长期面临"医生找不到企业、企业找不准项目"的对接之困。如今，在河北， 这一痛点正被一个数字化平台破解。河北省药监局打造的"河北省医疗器械创新服务平台"（以下简称平 台），正以"一站式"线上服务，打通从临床创意到产业成果落地的关键路径。 目前，平台已开展试运行，并成功推动一批临床项目与企业实现合作，显著提升了转化效率。截至2026 年1月，平台已收集临床创新创意126个，并从中筛选出52个临床价值明确、转化前景良好的优质项目纳 入储备。 数据归集夯实根基 平台以"项目库、企业库、专家库、法规库"为核心数据支撑，打破信息壁垒，推动创新要素集聚，实 现"一网归集、动态更新"。 目前，项目库已收录临床项目50余项，涵盖心血管、骨科、影像等重点领域。每个项目均建立了详细的 信息档案，不仅包含项目名称、研发团队、技术原理、创新点等基础内容，还精准标注了转化需求、合 作模式、市场预估等关键信息。通过标准化的数据录入与分类 ...

董事努力探索新的机遇，以提升本集团的业绩。该合作将使本集团多元化业务，并拓宽收入来源。董事 对澄迈钧立业务的长远前景持乐观态度，并认为潜在合作符合本集团及本公司股东的整体利益。 智通财经APP讯，皓文控股(08019)发布公告，于2026年2月11日，本公司与澄迈钧立橡胶有限公司(澄迈 钧立)订立一项不具法律约束力的谅解备忘录(谅解备忘录)。 根据谅解备忘录，本公司及澄迈钧立将开展战略性合作，以发展及拓展澄迈钧立的业务(尤以天然橡胶 及相关农业领域为重)。本公司与澄迈钧立将探索在农业及相关产业应用生物科技、智能技术及绿色科 技，致力于构建数字化平台，推动专利成果的复製与商业化，并透过香港实现海外扩张。 ...

格隆汇2月11日丨皓文控股(08019.HK)公告，于2026年2月11日，公司与澄迈钧立橡胶有限公司("澄迈钧 立")订立一项不具法律约束力的谅解备忘录。 根据谅解备忘录，公司及澄迈钧立将开展战略性合作，以发展及拓展澄迈钧立的业务(尤以天然橡胶及 相关农业领域为重)。公司与澄迈钧立将探索在农业及相关产业应用生物科技、智能技术及绿色科技， 致力于构建数字化平台，推动专利成果的复制与商业化，并透过香港实现海外扩张。 董事努力探索新的机遇，以提升集团的业绩。该合作将使集团多元化业务，并拓宽收入来源。董事对澄 迈钧立业务的长远前景持乐观态度，并认为潜在合作符合集团及公司股东的整体利益。 ...

董事努力探索新的机遇，以提升本集团的业绩。该合作将使本集团多元化业务，并拓宽收入来源。董事 对澄迈钧立业务的长远前景持乐观态度，并认为潜在合作符合本集团及本公司股东的整体利益。 根据谅解备忘录，本公司及澄迈钧立将开展战略性合作，以发展及拓展澄迈钧立的业务(尤以天然橡胶 及相关农业领域为重)。本公司与澄迈钧立将探索在农业及相关产业应用生物科技、智能技术及绿色科 技，致力于构建数字化平台，推动专利成果的复製与商业化，并透过香港实现海外扩张。 皓文控股(08019)发布公告，于2026年2月11日，本公司与澄迈钧立橡胶有限公司(澄迈钧立)订立一项不 具法律约束力的谅解备忘录(谅解备忘录)。 ...

中国燃气紧扣"科技驱动型综合能源及美好生活服务商"的战略发展规划，结合广西地区得天独厚的自然禀赋，打破业务边 界，拓展能源发展空间，把握综合能源市场发展机遇，重点开拓生物质能源、光伏、售电、绿色低碳、零碳产业等各项新业 务。以广西为"桥头堡"，深化与东盟国家行业协会及能源企业的标准互认与技术交流，优先进入越南、柬埔寨、印尼等燃气需 求快速增长的新兴市场，布局基础民生领域、工业配套服务、新能源融合业务，试点"燃气+分布式光伏""燃气+生物质发电"等 多能互补项目，积极探索跨境能源合作新路径，赋能东南亚国家能源结构转型。 2025年9月份，中国燃气亮相中国—东盟建筑科技展，其间与崇左市高新区、凭祥产业园签订零碳园区投资合作框架协 议，与维尔利环保科技集团股份有限公司、广西中桓能源有限公司签订战略服务协议，探索综合能源在现实场景的推广应用， 携手共建可持续的生物质能源产业链。同时，与百色市德保县人民政府签订战略合作协议，共建"绿铝+"新一代综合能源产业 基地，驱动工业绿色转型。中国燃气倡议提出"广西能耗双控及双碳数字化平台"，并推动平台一期工程完工，实现省级—城市 —企业三级能源数据、碳排放数据整合，接入林业碳汇区 ...

九彩果鲜在市场中的竞争优势是什么？ 九彩果鲜通过优质产品、稳定供应链和多渠道销售策略，在市场中获得了较强的竞争优势，确保了其生 存能力。 九彩果鲜采用了独特的经营模式，结合线上线下渠道，打造了全方位的销售体系。公司通过建立强大的 供应链管理，实现了从产地到消费者手中的高效流转。与此同时，九彩果鲜具有严格的产品质量监控体 系，确保每一批水果都符合标准，提高了消费者的信任度。此外，该品牌在市场上展现出强大的竞争 力，提供差异化的产品和服务，比如长期稳定的合作关系及良好的售后服务，从而进一步增强用户黏 性。这种灵活多变的经营策略，使九彩果鲜在竞争激烈的市场环境中始终保持领先地位。 九彩果鲜凭借其优质的产品和稳定的供应链，展现了强劲的生存能力。通过采用现代冷链物流和区块链 技术，九彩果鲜确保了产品的新鲜度和品质，使得客户的损耗风险大幅降低。此外，九彩果鲜与多个优 秀的农批市场保持紧密合作，这为其在竞争激烈的市场中立足提供了保障。展望未来，九彩果鲜计划进 一步拓展销售网络，深入开发华南及西南地区，从而增强品牌影响力和市场份额。结合以上策略，可以 看出九彩果鲜具备良好的发展潜力，有望在生鲜水果市场上继续保持领先地位。 九 ...

三是构建全生命周期服务生态。三方将推动保险服务从传统车险向智能保险、续保管理、出行保障等车生态场景延伸，并深度嵌入金标大众汽车销售与售后 服务全流程。 "我们将聚焦三方面：一是迭代数字化平台，实现投保、理赔无缝衔接；二是深化场景化保险服务包创新；三是完善智能定价体系，推动服务从'数字 化'向'智能化'升级。" 车车科技总裁尚妍妍称。 法巴天星保险总经理朱仁栋表示，期待围绕产品创新、服务闭环与生态共建三大维度，开发契合新能源汽车技术特性的智驾险与场景化产品，整合汽车销 售、保险与售后资源，打造一站式解决方案，树立跨界协同新标杆。（南木） 当前，新能源车险正从规模扩张迈向高质量发展阶段。L3级有条件自动驾驶车型进入量产交付，对风险精准识别与差异化定价提出新要求。此次合作，标 志着车企、险企与科技平台三方协同探索新型车险模式的实质性落地。 根据协议，三方将发挥各自优势：法巴天星保险负责保险产品设计与承保；车车科技提供嵌入式保险SaaS系统，涵盖新能源车险系统开发、智能定价模型开 发、全流程数字化运营及智能理赔；金标大众将推动保险服务深度融入购车、用车等核心场景。合作将重点推进三大方向： 一是创新产品开发。三方将联合 ...

Core Viewpoint - The national student registration information management system has been upgraded to provide a standardized, centralized, and efficient digital platform for managing student records across various educational administrative levels [1] Group 1: System Upgrade and Features - The upgraded system is deployed by the Ministry of Education and operates on a five-level application model, integrating core functions such as registration, transfer, promotion, and graduation [1] - The system significantly enhances the efficiency of cross-province transfer processes compared to the previous version [1] - It optimizes identity information verification and improves the comparison mechanism with the national population database to address issues like duplicate and inactive student records [1] Group 2: Data Utilization and Security - The system provides valuable data support for various educational initiatives, including dropout prevention, student funding, financial support, and examination admissions [1] - It also aids in the construction of the national population database and the implementation of personal income tax reforms related to children's education deductions [1] - Strict security management protocols are established, including tiered account authorization, operation tracking, and archiving inactive accounts to protect student personal information [1]